Verification evidence is still being completed.
PDF / print export
Anocca
Sodertalje, Sweden
- Verified lead
- Reagan Jarvis
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer, Scientific Founder
- 2026 technical specialization
- TCR-T Cell Therapy, Cellular Immunotherapy, Oncology, In-House Manufacturing, and Engineered Immunity
- Review cycle
- May 2026
- Full address
- Anocca AB, Forskargatan 20C, 151 36 Sodertalje, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Anocca company page confirming the Sodertalje address.
- Editorial note
- Anocca is published because official company materials confirm current leadership, Sodertalje operating address, and a substantial T-cell immunotherapy and manufacturing platform.
TCR-T Cell Therapy, Cellular Immunotherapy, Oncology, In-House Manufacturing, and Engineered Immunity
Official leadership disclosure, Official Sodertalje address disclosure, In-house manufacturing platform disclosure
Anocca is published because official company materials confirm current leadership, Sodertalje operating address, and a substantial T-cell immunotherapy and manufacturing platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Sodertalje, Sweden
Anocca
TCR-T Cell Therapy, Cellular Immunotherapy, Oncology, In-House Manufacturing, and Engineered Immunity · Clinical-stage cell-therapy platform
Anocca runs tcr-t cell therapy development, cell-therapy manufacturing, and oncology program development in Sodertalje, Sweden.
- Lead
- Reagan Jarvis (verified ↗)
- Address
- Anocca AB, Forskargatan 20C, 151 36 Sodertalje, Sweden (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical-stage cell-therapy platform
- Capabilities
- TCR-T Cell Therapy Development · Cell-Therapy Manufacturing · Oncology Program Development
- Founded
- 2014
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Reagan Jarvis
Chief Executive Officer, Scientific Founder
Full addressAnocca AB, Forskargatan 20C, 151 36 Sodertalje, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage cell-therapy platform
Sodertalje, Sweden. TCR-T Cell Therapy, Cellular Immunotherapy, Oncology, In-House Manufacturing, and Engineered Immunity. Review completed on 21 Mar 2026.
Swedish corporate, cell-therapy, and clinical-development oversight
Official leadership disclosure, Official Sodertalje address disclosure, In-house manufacturing platform disclosure
TCR-T Cell Therapy, Cellular Immunotherapy, Oncology, In-House Manufacturing, and Engineered Immunity
Anocca is published because official company materials confirm current leadership, Sodertalje operating address, and a substantial T-cell immunotherapy and manufacturing platform.
Editorial note
Anocca is published because official company materials confirm current leadership, Sodertalje operating address, and a substantial T-cell immunotherapy and manufacturing platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
TCR-T Cell Therapy Development
Cell-Therapy Manufacturing
Oncology Program Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
T-cell engineering workflow
In-house manufacturing systems
Platform immunology infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Anocca located?
- Anocca operates from Anocca AB, Forskargatan 20C, 151 36 Sodertalje, Sweden, Sodertalje, Sweden.
- Who runs Anocca?
- Anocca is led by Reagan Jarvis, Chief Executive Officer, Scientific Founder. Verified 21 Mar 2026.
- What does Anocca do?
- Anocca runs tcr-t cell therapy development, cell-therapy manufacturing, and oncology program development in Sodertalje, Sweden. Core capabilities: TCR-T Cell Therapy Development, Cell-Therapy Manufacturing, Oncology Program Development.
Editorial context
Related technical briefs
Briefs that name Sodertalje as a covered market or city.